TABLE 4.

FORT and FOI in different POSEIDON groups according to the use of agonist vs. antagonist protocol.

		FORT	P-value	FOI	P-value
Group 1	Agonist	0.79 (0.76, 0.82)	0.376	0.72 (0.69, 0.75)	1.000
	Antagonist	0.76 (0.73, 0.79)		0.71 (0.68, 0.75)
Group2	Agonist	0.76 (0.72, 0.81)	0.760	0.68 (0.64, 0.72)	0.463
	Antagonist	0.73 (0.69, 0.77)		0.69 (0.65, 0.73)
Group3	Agonist	1.37 (1.29, 1.44)	0.034	1.23 (1.16, 1.31)	0.889
	Antagonist	1.28 (1.22, 1.35)		1.23 (1.17, 1.30)
Group4	Agonist	1.20 (1.14, 1.27)	0.132	1.05 (0.99, 1.11)	0.966
	Antagonist	1.12 (1.07, 1.17)		1.02 (0.97, 1.07)
Group5	Agonist	0.85 (0.84, 0.85)	<0.001	0.84 (0.83, 0.84)	<0.001
	Antagonist	0.85 (0.84, 0.87)		0.83 (0.82, 0.85)
Total			0.04		0.008

FORT, follicular output rate; FOI, follicle-to-oocyte index. Arithmetic mean (95% CI)/N (%) calculated using EmpowerStats (www.empowerstats.com) and R. Kruskal-Wallis rank test for continuous variables.